RegeneRx Biopharmaceuticals, Inc. (RGRX) has a market capitalization of $748.00 and trades at $0.00. The 52-week range is 0.0002-0.163.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-1.00, annual revenue of $76.76K.
The stock has a beta of 4.73, operates in the Healthcare sector.
